---
title: "STAAR Surgical Company (STAA.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/STAA.US.md"
symbol: "STAA.US"
name: "STAAR Surgical Company"
industry: "Health Care Supplies"
datetime: "2026-05-19T19:29:38.069Z"
locales:
  - [en](https://longbridge.com/en/quote/STAA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/STAA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/STAA.US.md)
---

# STAAR Surgical Company (STAA.US)

## Company Overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | US Market |
| Website | [www.staar.com](https://www.staar.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:14.000Z

**Overall: B (0.39)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 7 / 45 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 4.03% |  |
| Net Profit YoY | 70.41% |  |
| P/B Ratio | 4.57 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1608666273.45 |  |
| Revenue | 290375000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -5.99% | D |
| Profit Margin | -7.24% | D |
| Gross Margin | 73.63% | A |
| Revenue YoY | 4.03% | C |
| Net Profit YoY | 70.41% | A |
| Total Assets YoY | -1.37% | D |
| Net Assets YoY | 0.68% | C |
| Cash Flow Margin | 238.65% | A |
| OCF YoY | 4.03% | C |
| Turnover | 0.64 | B |
| Gearing Ratio | 21.89% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - STAAR Surgical Company",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "4.03%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "70.41%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.57",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "1608666273.45",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "290375000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "-5.99%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-7.24%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "73.63%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "4.03%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "70.41%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-1.37%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.68%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "238.65%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "4.03%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.64",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "21.89%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -76.49 | 44/45 | - | - | - |
| PB | 4.57 | 31/45 | 3.93 | 3.32 | 2.53 |
| PS (TTM) | 5.54 | 35/45 | 5.88 | 5.05 | 3.41 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Essilor (ESLOY.US) | B | B | C | B | B | B |
| 02 | HOYA Corporation (HOCPY.US) | A | C | B | A | B | B |
| 03 | Align (ALGN.US) | B | C | B | B | C | B |
| 04 | Lantheus (LNTH.US) | A | C | B | C | C | B |
| 05 | Merit Medical (MMSI.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-15T04:00:00.000Z

Total Analysts: **11**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 27% |
| Hold | 8 | 73% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 32.80 |
| Highest Target | 27.00 |
| Lowest Target | 16.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/STAA.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/STAA.US/norm.md)
- [Related News](https://longbridge.com/en/quote/STAA.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/STAA.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**